US Pharma MarketingAsymBio to secure $184m to support growth in biologics manufacturing
Biologics CDMO AsymBio is set to secure $184m in funding from Asymchem Group, Hillhouse Qirui and other investors to support long-term growth.
Biologics CDMO AsymBio is set to secure $184m in funding from Asymchem Group, Hillhouse Qirui and other investors to support long-term growth.
Source: Pharmaceutical Technology